By using SPECT/CT and PET/CT imaging methods, Bala et al. (2018) assessed the ability of the nanobody cAbMMR3.49 to target the macrophage mannose receptor (MMR), which is expressed by macrophages in atherosclerosis. This evidence concerns the gene MRC1 and atherosclerosis.